Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:New insights in ATP synthesis as therapeutic target in cancer and angiogenic ocular diseases
Authors:ID Noorden, Cornelis J. F. van (Author)
ID Yetkin-Arik, Bahar (Author)
ID Serrano Martinez, Paola (Author)
ID Bakker, Noëlle (Author)
ID Breest Smallenburg, Mathilda E. van (Author)
ID Schlingemann, Reinier O. (Author)
ID Klaassen, Ingeborg (Author)
ID Majc, Bernarda (Author)
ID Habič, Anamarija (Author)
ID Bogataj, Urban (Author)
ID Galun, Katrin S. (Author)
ID Vittori, Miloš (Author)
ID Erdani-Kreft, Mateja (Author)
ID Novak, Metka (Author)
ID Breznik, Barbara (Author)
ID Hira, Vashendriya V. V. (Author)
Files:URL URL - Source URL, visit https://doi.org/10.1369/00221554241249515
 
.pdf PDF - Presentation file, download (3,75 MB)
MD5: 31C5087AE9BFCAD3C92294006360F688
 
Language:English
Typology:1.02 - Review Article
Organization:Logo NIB - National Institute of Biology
Abstract:Lactate and ATP formation by aerobic glycolysis, the Warburg effect, is considered a hallmark of cancer. During angiogenesis in non-cancerous tissue, proliferating stalk endothelial cells (ECs) also produce lactate and ATP by aerobic glycolysis. In fact, all proliferating cells, both non-cancer and cancer cells, need lactate for the biosynthesis of building blocks for cell growth and tissue expansion. Moreover, both non-proliferating cancer stem cells in tumors and leader tip ECs during angiogenesis rely on glycolysis for pyruvate production, which is used for ATP synthesis in mitochondria through oxidative phosphorylation (OXPHOS). Therefore, aerobic glycolysis is not a specific hallmark of cancer but rather a hallmark of proliferating cells and limits its utility in cancer therapy. However, local treatment of angiogenic eye conditions with inhibitors of glycolysis may be a safe therapeutic option that warrants experimental investigation. Most types of cells in the eye such as photoreceptors and pericytes use OXPHOS for ATP production, whereas proliferating angiogenic stalk ECs rely on glycolysis for lactate and ATP production.
Keywords:aerobic glycolysis, anaerobic glycolysis, angiogenesis, ATP synthesis, cancer cells, cancer stem cells, endothelial cells, energy metabolism, eye diseases, oxidative phosphorylation, pericytes, retina, Warburg effect
Publication status:Published
Publication version:Version of Record
Publication date:01.05.2024
Year of publishing:2024
Number of pages:str. 329-352
Numbering:Vol. 72, iss. 5
PID:20.500.12556/DiRROS-19117 New window
UDC:576
ISSN on article:0022-1554
DOI:10.1369/00221554241249515 New window
COBISS.SI-ID:199290115 New window
Note:Soavtorji: Bahar Yetkin-Arik, Paola Serrano Martinez, Noëlle Bakker, Mathilda E. van Breest Smallenburg, Reinier O. Schlingemann, Ingeborg Klaassen, Bernarda Majc, Anamarija Habič, Urban Bogataj, S. Katrin Galun, Miloš Vittori, Mateja Erdani Kreft, Metka Novak, Barbara Breznik, and Vashendriya V.V. Hira;
Publication date in DiRROS:18.06.2024
Views:426
Downloads:224
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:The Journal of histochemistry and cytochemistry
Shortened title:J Histochem Cytochem
Publisher:Williams & Wilkins Co.
ISSN:0022-1554
COBISS.SI-ID:6404615 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-2526
Name:Razkrivanje niše matičnih glioma celic v iskanju novih terapevtskih ciljev pri bolnikih z glioblastomom

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-4504-2022
Name:Z vizualizacijo mikrookolja glioblastoma do boljše terapije

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:NC-0023-2022
Name:Inovativne sonde in inhibicija metaloproteaz za ciljanje glioblastomskih matičnih celic v tumorskem mikrooklju

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0245-2019
Name:Ekotoksiologija, toksikološka genomika in karcinogeneza

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P3-0108-2018
Name:Diferenciacija urotelijskih celic

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:Z3-1870-2019
Name:Vpliv mezenhimskih matičnih celic na odpornost glioblastoma na terapijo

Funder:Other - Other funder or multiple funders
Funding programme:Postdoctoral project
Project number:Z3-1870

Funder:Other - Other funder or multiple funders
Funding programme:European Program of Cross-Border Cooperation for Slovenia-Italy Interreg
Acronym:TRANSGLIOMA

Funder:Other - Other funder or multiple funders
Funding programme:EFSD/Boehringer Ingelheim European Research Program in Microvascular Complications of Diabetes
Project number:BI18_4

Funder:Other - Other funder or multiple funders
Funding programme:Eye Funds
Project number:UZ2019-23

Funder:Other - Other funder or multiple funders
Funding programme:Novartis
Project number:2021-0224

Licences

License:CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:http://creativecommons.org/licenses/by-nc/4.0/
Description:A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.

Secondary language

Language:Slovenian
Keywords:rak, onkologija, rakave celice, bolezni oči, metabolizem, angiogeneza


Back